csirt@kutim:~/threat-intel/cve/CVE-2026-2439

Katalog CVE

CVSS 9.8 · Critical EPSS 0,43%

Kerentanan Use of Cryptographically Weak Pseudo-Random Number Generator (PRNG) pada bva concierge. Skor CVSS 3.1 9.8 (Critical) menurut CISA ADP.

Deskripsi (NVD)

Concierge::Sessions versions from 0.8.1 before 0.8.5 for Perl generate insecure session ids. The generate_session_id function in Concierge::Sessions::Base defaults to using the uuidgen command to generate a UUID, with a fallback to using Perl's built-in rand function. Neither of these methods are secure, and attackers are able to guess session_ids that can grant them access to systems. Specifically, * There is no warning when uuidgen fails. The software can be quietly using the fallback rand() function with no warnings if the command fails for any reason. * The uuidgen command will generate a time-based UUID if the system does not have a high-quality random number source, because the call does not explicitly specify the --random option. Note that the system time is shared in HTTP responses. * UUIDs are identifiers whose mere possession grants access, as per RFC 9562. * The output of the built-in rand() function is predictable and unsuitable for security applications.

Rincian

Terbit di NVD
16 Februari 2026
Terakhir diubah
17 Juni 2026
Status NVD
Analyzed
CVSS 3.1
9.8 (Critical), sumber CISA ADP
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H · uraikan di kalkulator
Jenis kelemahan (CWE)
CWE-338: Use of Cryptographically Weak Pseudo-Random Number Generator (PRNG)
CWE-340: Generation of Predictable Numbers or Identifiers
EPSS (30 hari)
0,43% peluang dieksploitasi; lebih tinggi dari 35,2% CVE lain

Produk dan versi terdampak

VendorProdukVersi terdampak
bva concierge Versi 0.8.1 hingga sebelum 0.8.5

> Data dari konfigurasi CPE di NVD.

Referensi dan perbaikan

Sumber: NVD · CVE.org · EPSS. Halaman ini disusun otomatis dari data tersebut; pembaruan terakhir 5 Okt 2026, 20:11 WITA. Kalau sistem di Perangkat Daerah memakai produk ini dan butuh bantuan, laporkan lewat kanal pelaporan.